GE Invests In Israeli Company Involved With Cancer Detection

JStone

Rookie
Jun 29, 2011
13,374
253
0
Warren Buffett
If you go to the Middle East looking for oil, you don't need to stop in Israel. But, if you're looking for brains, for energy, for integrity, for imagination, it's the only stop you need to make
http://www.youtube.com/watch?v=JbX60Pktzsk

GE Healthymagination Fund Invests in Check-Cap Ltd., Developer of Ingestible Imaging Capsule That Could Detect Colorectal Cancer
GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company (NYSE: GE), announced today an investment in Check-Cap, Ltd., a developer of an ingestible imaging capsule that may help detect colorectal cancer. The investment is being made through the GE healthymagination Fund, an equity fund that makes investments in highly promising healthcare technology companies.

“Over the past 15 years GE Healthcare has benefited from Israel’s spirit of innovation and scientific discoveries”
.Check-Cap’s ingestible and disposable imaging capsule is planned to have the capability to image the colon in 3D. The capsule will require no bowel cleansing before ingestion and no hospital visit, allowing patients to go about their daily routines without having to alter their activities.

“Check-Cap’s technology is not only innovative but it presents great promise to change the standard of patient care and to help them avoid the discomfort of traditional colonoscopies,” said GE Vice President & GE Healthcare Chief Technology Officer Mike Harsh.

The investment is aligned with GE Healthcare’s expanding focus on colon cancer management solutions that can improve healthcare globally, as well as GE’s broader healthymagination initiative, which focuses on reducing cost, increasing patient access and improving quality in healthcare. Financial terms of the transaction were not disclosed.

Colorectal cancer is the third most common cancer in men and the second in women, according to the International Agency for Research on Cancer. Almost 60% of the cases occur in developed regions. About 608,000 deaths from colorectal cancer are estimated worldwide annually, accounting for 8% of all cancer deaths and making it the fourth most common cause of death from cancer. In the United States, colorectal cancer is the 3rd most common and the 2nd leading cause of cancer death.

GE healthymagination Fund Invests in Check-Cap Ltd., Developer of Ingestible Imaging Capsule That Could Detect Colorectal Cancer | Business Wire
 
Last edited:

Forum List

Back
Top